Ezetimibe and Labyrinthitis - a phase IV clinical study of FDA data

Summary:

Labyrinthitis is reported as a side effect among people who take Ezetimibe (ezetimibe), especially for people who are male, 60+ old, also take Sandostatin, and have Acromegaly.

The phase IV clinical study analyzes which people have Labyrinthitis when taking Ezetimibe. It is created by eHealthMe based on reports of 30,221 people who have side effects when taking Ezetimibe from the FDA, and is updated regularly.

What is Ezetimibe?

Ezetimibe has active ingredients of ezetimibe. It is often used in high blood cholesterol. eHealthMe is studying from 30,849 Ezetimibe users. Check the latest studies of Ezetimibe.

What is Labyrinthitis?

Labyrinthitis (inflammation of the labyrinth or inner ear) is found to be associated with 412 drugs and 1,021 conditions by eHealthMe. Check the latest studies of Labyrinthitis.

On Aug, 10, 2026

30,221 people reported to have side effects when taking Ezetimibe.
Among them, 15 people (0.05%) have Labyrinthitis.

Among these 15 people:

What is the gender of people who have Labyrinthitis when taking Ezetimibe? *

female: 15.38 %
male: 84.62 %

What is the age of people who have Labyrinthitis when taking Ezetimibe? *

What are other drugs people take besides Ezetimibe? *

Sandostatin: 11 people, 73.33%
Asa: 7 people, 46.67%
Metformin: 6 people, 40.00%
Simvastatin: 1 person, 6.67%
Pantoprazole: 1 person, 6.67%
Omeprazole: 1 person, 6.67%
Mometasone Furoate: 1 person, 6.67%
Metformin Hydrochloride: 1 person, 6.67%
Innohep: 1 person, 6.67%
Gliclazide: 1 person, 6.67%

What are other side effects people have besides Labyrinthitis? *

High Blood Pressure: 12 people, 80.00%
Injection Site Pain: 12 people, 80.00%
Body Temperature Decreased: 11 people, 73.33%
Blood Pressure Diastolic Decreased: 11 people, 73.33%
Injection Site Haemorrhage (bleeding from injection site): 11 people, 73.33%
Otitis (ear infection): 11 people, 73.33%
Heart Rate Decreased: 11 people, 73.33%
Upper Respiratory Tract Infection: 11 people, 73.33%
Blood Pressure Diastolic Increased: 8 people, 53.33%
Influenza Like Illness: 7 people, 46.67%

What are the existing conditions these people have? *

Acromegaly (body produces too much growth hormone, leading to excess growth of body tissues): 11 people, 73.33%
Diabetes: 4 people, 26.67%
Blood Pressure Abnormal: 4 people, 26.67%
Quit Smoking: 1 person, 6.67%
Oesophagitis (inflammation of oesophagus): 1 person, 6.67%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 1 person, 6.67%
Gastritis (inflammation of stomach): 1 person, 6.67%
Carcinoid Tumor: 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Ezetimibe and have Labyrinthitis?

- Check whether Labyrinthitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Ezetimibe:

Ezetimibe (30,849 reports)

Labyrinthitis treatments and more:

Labyrinthitis (4,138 reports)

Browse all side effects of Ezetimibe:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Labyrinthitis:

Labyrinthitis (412 drugs)

Browse all the conditions that are associated with Labyrinthitis:

Labyrinthitis (1,021 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on ezetimibe (the active ingredients of Ezetimibe) and Ezetimibe (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.